Pierre Koch

1.7k total citations
79 papers, 1.3k citations indexed

About

Pierre Koch is a scholar working on Organic Chemistry, Molecular Biology and Inorganic Chemistry. According to data from OpenAlex, Pierre Koch has authored 79 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Organic Chemistry, 48 papers in Molecular Biology and 14 papers in Inorganic Chemistry. Recurrent topics in Pierre Koch's work include Synthesis and biological activity (32 papers), Melanoma and MAPK Pathways (23 papers) and Crystal structures of chemical compounds (13 papers). Pierre Koch is often cited by papers focused on Synthesis and biological activity (32 papers), Melanoma and MAPK Pathways (23 papers) and Crystal structures of chemical compounds (13 papers). Pierre Koch collaborates with scholars based in Germany, Palestinian Territory and Egypt. Pierre Koch's co-authors include Stefan Laufer, Stefan Knapp, A. Chaikuad, Matthias Gehringer, Michael E. Jung, Frank M. Boeckler, Verena Schattel, Andreas Lange, Markus O. Zimmermann and Márcia Inês Goettert and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Pierre Koch

73 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Koch Germany 22 757 698 180 148 143 79 1.3k
Steven E. Hall United States 20 952 1.3× 574 0.8× 124 0.7× 139 0.9× 126 0.9× 40 1.5k
L. W. Lawrence Woo United Kingdom 35 1.6k 2.1× 854 1.2× 133 0.7× 193 1.3× 216 1.5× 61 2.9k
Martin Rowlands United Kingdom 29 1.5k 2.0× 637 0.9× 252 1.4× 148 1.0× 273 1.9× 67 2.6k
Nan‐Horng Lin United States 30 1.5k 2.0× 953 1.4× 159 0.9× 334 2.3× 317 2.2× 67 2.1k
Gyochang Keum South Korea 22 668 0.9× 905 1.3× 109 0.6× 128 0.9× 56 0.4× 95 1.4k
G. Pochetti Italy 26 1.2k 1.6× 408 0.6× 105 0.6× 168 1.1× 285 2.0× 73 1.7k
John W. Ellingboe United States 25 893 1.2× 906 1.3× 137 0.8× 113 0.8× 122 0.9× 54 1.8k
Mary J. Meegan Ireland 26 766 1.0× 1.2k 1.7× 224 1.2× 199 1.3× 193 1.3× 99 1.9k
Elisabetta Orlandini Italy 25 869 1.1× 524 0.8× 129 0.7× 239 1.6× 440 3.1× 103 1.7k
Carmen Almansa Spain 22 578 0.8× 705 1.0× 107 0.6× 197 1.3× 44 0.3× 51 1.4k

Countries citing papers authored by Pierre Koch

Since Specialization
Citations

This map shows the geographic impact of Pierre Koch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Koch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Koch more than expected).

Fields of papers citing papers by Pierre Koch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Koch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Koch. The network helps show where Pierre Koch may publish in the future.

Co-authorship network of co-authors of Pierre Koch

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Koch. A scholar is included among the top collaborators of Pierre Koch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Koch. Pierre Koch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sellmer, Andreas, Karsten Spiekermann, Maria Reinecke, et al.. (2025). Novel water-soluble and highly efficient dual type I/II next generation inhibitors of FMS-like tyrosine kinase 3 (FLT3). European Journal of Medicinal Chemistry. 296. 117849–117849. 2 indexed citations
2.
3.
Quintanilla-Martı́nez, Leticia, Irene González-Menéndez, Ulrike Naumann, et al.. (2023). Efficacy of combined tumor irradiation and KCa3.1-targeting with TRAM-34 in a syngeneic glioma mouse model. Scientific Reports. 13(1). 20604–20604. 5 indexed citations
4.
Kopanchuk, Sergei, Dieter Schollmeyer, Steffen Lüdeke, et al.. (2022). Structure-Based Design of High-Affinity Fluorescent Probes for the Neuropeptide Y Y1 Receptor. Journal of Medicinal Chemistry. 65(6). 4832–4853. 15 indexed citations
5.
Costales, Paula, Luz Elena Núñez, Jesús Cortés, et al.. (2021). Genetic Engineering in Combination with Semi‐Synthesis Leads to a New Route for Gram‐Scale Production of the Immunosuppressive Natural Product Brasilicardin A. Angewandte Chemie International Edition. 60(24). 13536–13541. 13 indexed citations
6.
Schollmeyer, Dieter, et al.. (2021). 1-{3-[(7-Fluoro-9H-pyrimido[4,5-b]indol-4-yl)(methyl)amino]piperidin-1-yl}propan-1-one. SHILAP Revista de lepidopterología. 6(2). x210159–x210159.
7.
Koch, Pierre, et al.. (2021). Evaluation of Novel Substituted Furopyridines as Inhibitors of Protein Kinases Related to Tau Pathology in Alzheimer´s Disease. Medicinal Chemistry. 17(8). 844–855. 4 indexed citations
8.
9.
Tesch, Roberta, Tatu Pantsar, Eva Döring, et al.. (2019). Pyridinylimidazoles as dual glycogen synthase kinase 3β/p38α mitogen-activated protein kinase inhibitors. European Journal of Medicinal Chemistry. 175. 309–329. 26 indexed citations
10.
11.
Koch, Pierre, Andreas Brunschweiger, Vigneshwaran Namasivayam, et al.. (2018). Probing Substituents in the 1- and 3-Position: Tetrahydropyrazino-Annelated Water-Soluble Xanthine Derivatives as Multi-Target Drugs With Potent Adenosine Receptor Antagonistic Activity. Frontiers in Chemistry. 6. 206–206. 11 indexed citations
12.
Boeckler, Frank M., et al.. (2017). Fluorescence polarization-based competition binding assay for c-Jun N-terminal kinases 1 and 2. Analytical Biochemistry. 532. 26–28. 8 indexed citations
13.
Brunschweiger, Andreas, Pierre Koch, Muhammad Rafehi, et al.. (2016). 8-Substituted 1,3-dimethyltetrahydropyrazino[2,1-f]purinediones: Water-soluble adenosine receptor antagonists and monoamine oxidase B inhibitors. Bioorganic & Medicinal Chemistry. 24(21). 5462–5480. 20 indexed citations
14.
15.
16.
Gehringer, Matthias, et al.. (2015). c-JunN-terminal kinase inhibitors: a patent review (2010 – 2014). Expert Opinion on Therapeutic Patents. 25(8). 849–872. 45 indexed citations
17.
Brunschweiger, Andreas, Pierre Koch, Sonja Hinz, et al.. (2014). 8‐Benzyltetrahydropyrazino[2,1‐f]purinediones: Water‐Soluble Tricyclic Xanthine Derivatives as Multitarget Drugs for Neurodegenerative Diseases. ChemMedChem. 9(8). 1704–1724. 21 indexed citations
18.
Koch, Pierre, Andreas Brunschweiger, Thomas Borrmann, et al.. (2013). 1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases. Bioorganic & Medicinal Chemistry. 21(23). 7435–7452. 25 indexed citations
19.
Laufer, Stefan, et al.. (2010). Tri- and tetrasubstituted imidazoles as p38α mitogen-activated protein kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(22). 6671–6675. 32 indexed citations
20.
Allen, Fred L., Pierre Koch, & H. Suschitzky. (1959). Heterocyclic fluorine compounds—III. Tetrahedron Letters. 1(2). 26–26. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven E. Hall Breakdown of academic impact, for papers by L. W. Lawrence Woo Breakdown of academic impact, for papers by Martin Rowlands Breakdown of academic impact, for papers by Nan‐Horng Lin Breakdown of academic impact, for papers by Gyochang Keum Breakdown of academic impact, for papers by G. Pochetti Breakdown of academic impact, for papers by John W. Ellingboe Breakdown of academic impact, for papers by Mary J. Meegan Breakdown of academic impact, for papers by Elisabetta Orlandini Breakdown of academic impact, for papers by Carmen Almansa
Rankless by CCL
2026